Position in SRRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,216,705
+$4,312,838 QoQ
Shares Held
113,031
+191.9% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 304 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Derivatives in SRRK
reported options exposure · as of Dec 31, 2024CallValue
$1,728,800
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. SRRK ranks #57 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in SRRK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,216,705 | 113,031 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $1,903,867 | 38,728 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $885,844 | 20,110 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $644,623 | 17,310 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,830,079 | 51,668 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $4,780,190 | 148,684 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,728,800 | 40,000 | Call | Defined | 2025-02-12 | |
| 2024-12-31 | $4,251,160 | 98,361 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,315,994 | 289,138 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,243,109 | 269,281 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $9,525,203 | 536,329 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $934,547 | 49,710 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $5,907 | 832 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $77,903 | 10,332 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $916,800 | 114,600 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,038,035 | 114,700 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $25,481 | 3,677 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $10,386 | 1,892 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $185,616 | 14,400 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,436,844 | 57,844 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $938,065 | 28,409 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $3,166,023 | 109,551 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,126,836 | 61,722 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $302,244 | 6,228 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $54,255 | 3,067 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $621,507 | 34,130 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $84,624 | 6,988 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||